Sign in
Active, not recruitingNo phase

Poly-omic Predictors of Symptom Duration and Recovery for Adolescent Concussion

Key facts

Who runs it
Milton S. Hershey Medical Center
Where
Boston, Cincinnati, Hershey, New York, and Syracuse, United StatesSee the 5 sites
Trial code
Status
Active, not recruiting
People taking part
750 people, planned
Started
18 Jan 2021
Expected to end
Dec 2027
Type of study
Observational
Record updated
8 September 2026

Who can take part

Age
5 years to 24 years
Sex
Women and men
Healthy volunteers
Cannot take part

The registry criteria, word for word

Show all 19 criteriaShow less

Who can take part

  • Presence of mTBI: defined by criteria from the Berlin Consensus Statement and WHO. Assessment for mTBI status be performed by a licensed clinician per the 2018 CDC guidelines
  • Age at enrollment: 5-24 years of age (inclusive)

Who cannot take part

  • Previous moderate-to-severe TBI requiring overnight hospitalization
  • Unresolved symptoms from previous concussion, or any concussion within the last 3 months
  • Psychiatric illness requiring previous hospitalization
  • Previous neurosurgery
  • Previously enrolled in the same study
  • Neurological condition (e.g. epilepsy, hydrocephalus) or abnormality on neuroimaging (if performed)
  • Upper respiratory infection
  • Periodontal infection
  • >7d after initial mTBI
  • Glasgow Coma Scale score of 13 or less
  • Abbreviated Injury Scale (AIS) score > 3 (to reduce confounding from poly-trauma)
  • Intellectual disability that prevents ability to provide informed assent
  • Pregnancy
  • Active substance use/dependence
  • Non-fluency in English
  • Injury to the oropharynx
  • Inability to complete follow-up assessments

Where in United States

  • Boston Children's HosptialBoston, United States
  • Cincinnati Children's Hospital Medical CenterCincinnati, United States
  • Penn State Milton S. Hershey Medical CenterHershey, United States
  • Weill Cornell Medicine-New York Presbyterian HospitalNew York, United States
  • SUNY Upstate Medical UniversitySyracuse, United States

About the trial

What the trial wants to find out

The purpose of this study is to identify changes in salivary micro ribonucleic acid (miRNA) levels that are predictive of symptom duration and character following mild traumatic brain injury (mTBI) in children.

Data and sources

Registry record
Listed on ClinicalTrials.gov.How to verify a trial in the registry
Record updated
8 September 2026